Renaissance國際IPO ETF IPOS 深 滬
等待開盤 05-18 09:30:00 美东时间
21.515
+0.035
+0.16%
華盛通- 最 高21.579
- 今 開21.48
- 成交量 1800股
- 最 低 21.48
- 昨 收 21.4801
- 總市值 1075.75万
- 52周最高 22.99
- 市盈率 靜 --
- 換手率 0.36%
- 52周最低 13.876
- 委 比 0.00%
- 總股本 50.00万
- 歷史最高 40.6502
- 量 比 0.41
- 振 幅 0.46%
- 歷史最低 10.6531
- 每 手 1
- 風險率 2.12%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多UPDATE 2-German defence firm Vincorion rises 17% on Frankfurt debut
UPDATE 2-German defence firm Vincorion rises 17% on Frankfurt debut Updates share move in paragraph 2, detail in paragraph 3, CEO quote in paragraph 4 and 9-12, comment in paragraphs 6 and 8, context in paragraph 7 By Maria Rugamer March 20 (Reuters) - Shares in German defence supplier Vincorion V1N
03-20 17:09
LIVE MARKETS-Stocks pricing in recession risk, not stagflation – HSBC
LIVE MARKETS-Stocks pricing in recession risk, not stagflation – HSBC Main US indexes modestly red; Dow off most, down ~0.5% Jan factory orders MM 0.1% vs 0.1% est Euro STOXX 600 index off ~0.5% Dollar rises; US crude up >2%; gold down >2%; bitcoin down >3% US 10-Year Treasury yield rises to ~4.22%
03-18 22:06
LIVE MARKETS-Blockbuster tech IPOs could supercharge US market by $3 trillion, LPL Financial estimates
LIVE MARKETS-Blockbuster tech IPOs could supercharge US market by $3 trillion, LPL Financial estimates US equity index futures decline; Dow off ~0.4% Euro STOXX 600 index off ~0.7% Dollar rises; US crude up >1%; gold, bitcoin both down >2% US 10-Year Treasury yield edges up ~4.22% Welcome to the hom
03-18 21:31
'Softbank's PayPay Set For Nasdaq Listing With QIA, Visa, Adia Backing; PayPay U.S. IPO To Draw $200M In Anchor Investment; PayPay Targets Valuation Of Up To $14B' - Reuters Exclusive Citing Sources
PayPay targets up to $14 billion valuation in IPOSoftBank seeks funds for AI investments through asset salesPayPay partners with Visa to expand in USFeb 27 (Reuters) - A group of global investors including Qatar
02-28 03:59
Chartwell Retirement Residences reports Q4 results
Chartwell Retirement Residences press release (CWSRF): Q4 Revenue of $292.5M beats by $73.1M. Funds from operations ("FFO")(1) increased $23.6 million or 40.9% in Q4 2025, and $80.6 million or 40.8% f...
02-27 23:03
Johnson & Johnson's New FDA Approval Lets Lung Cancer Patients Switch To Monthly Dosing Sooner
FDA approves monthly dosing for J&J's Rybrevant Faspro with Lazcluze, offering faster, easier treatment for EGFR lung cancer.
02-18 00:45
BRIEF-NYSE Says seven of 2025’s Top 10 IPOs Debuted on Its Exchange
Dec 15 (Reuters) - Intercontinental Exchange Inc ICE.N: NYSE CONTENT ADVISORY: PRE-MARKET UPDATE + SEVEN OF THE TOP 10 IPOS IN 2025 LIST ON NYSE Source text: ID:nPn9sMCTfa Further company coverage: IC...
2025-12-15 23:59
BRIEF-Clinical Data On Effect Of Sotagliflozin On Adipose Distribution In Non-Diabetic Patients
Dec 5 (Reuters) - Lexicon Pharmaceuticals Inc LXRX.O: CLINICAL DATA ON EFFECT OF SOTAGLIFLOZIN ON ADIPOSE DISTRIBUTION IN NON-DIABETIC PATIENTS WILL BE PRESENTED AT THE 2025 CARDIO VASCULAR CLINICAL T...
2025-12-05 21:42
BRIEF-Goldman Sachs CEO David Solomon Says This Week We Will Do More IPOs, Have More IPO Activity At Goldman Sachs Than We've Had Since July 2021 - CNBC
Sept 10 (Reuters) - GOLDMAN SACHS CEO DAVID SOLOMON: WE'VE SEEN SOME JOB DATA THAT INDICATES THAT THERE HAS BEEN SOME SOFTENING THE ECONOMY GOLDMAN SACHS CEO DAVID SOLOMON: THIS WEEK WE WILL DO MORE I...
2025-09-11 04:51
Johnson & Johnson Unveils Promising Data on RYBREVANT® for EGFR-Mutated Lung Cancer at WCLC 2025
Johnson & Johnson has announced new data concerning RYBREVANT® (amivantamab-vmjw) and an investigational subcutaneous version of the drug, highlighting enhanced outcomes for patients with epidermal gr...
2025-09-05 05:18
